Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filoche

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
Journal of Medicinal Chemistry|November 5, 2014
SAR156497, an exquisitely selective inhibitor of aurora kinasesJean-Christophe Carry, François Clerc, Hervé Minoux, et al.
Journal of Medicinal Chemistry|November 18, 2014
Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsBenoit Pasquier, Youssef El-Ahmad, Bruno Filoche-Rommé, et al.
Journal of Medicinal Chemistry|January 7, 2014
Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancersVictor Certal, Jean-Christophe Carry, Frank Halley, et al.
Journal of Medicinal Chemistry|November 14, 2019
Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3<i>S</i>)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7<i>H</i>-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast CancerYoussef El-Ahmad, Michel Tabart, Frank Halley, et al.
Ebiomedicine|April 2, 2025
Computational fluid dynamics of small airway disease in chronic obstructive pulmonary diseaseYousry K Mohamady, Vincent Geudens, Charlotte De Fays, et al.
ACS Infectious Diseases|February 22, 2022
Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic InstitutionsBen Gold, Jun Zhang, Landys Lopez Quezada, et al.
The American Journal of Gastroenterology|August 16, 2017
Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French AdolescentsSilvia Ghione, Hélène Sarter, Mathurin Fumery, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Journal of Medicinal Chemistry|November 5, 2014
SAR156497, an exquisitely selective inhibitor of aurora kinasesJean-Christophe Carry, François Clerc, Hervé Minoux, et al.
Journal of Medicinal Chemistry|November 18, 2014
Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsBenoit Pasquier, Youssef El-Ahmad, Bruno Filoche-Rommé, et al.
Journal of Medicinal Chemistry|January 7, 2014
Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancersVictor Certal, Jean-Christophe Carry, Frank Halley, et al.
Journal of Medicinal Chemistry|November 14, 2019
Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3<i>S</i>)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7<i>H</i>-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast CancerYoussef El-Ahmad, Michel Tabart, Frank Halley, et al.
Ebiomedicine|April 2, 2025
Computational fluid dynamics of small airway disease in chronic obstructive pulmonary diseaseYousry K Mohamady, Vincent Geudens, Charlotte De Fays, et al.
ACS Infectious Diseases|February 22, 2022
Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic InstitutionsBen Gold, Jun Zhang, Landys Lopez Quezada, et al.
The American Journal of Gastroenterology|August 16, 2017
Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French AdolescentsSilvia Ghione, Hélène Sarter, Mathurin Fumery, et al.
Pageof 22